Nigeria’s post-COVID-19 vaccine manufacturing ambitions: Opportunities and regional implications

Oyeronke Oyebanji, Olufunke Falade, Frederik Kristensen, David Heymann, Beate Kampmann

Open source

DOI
10.4102/jphia.v17i1.1560
Published
2026-02-02
Container
Journal of Public Health in Africa
Publisher
AOSIS
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.4102/jphia.v17i1.1560,
  title = {Nigeria’s post-COVID-19 vaccine manufacturing ambitions: Opportunities and regional implications},
  author = {Oyeronke Oyebanji and Olufunke Falade and Frederik Kristensen and David Heymann and Beate Kampmann},
  year = {2026},
  journal = {Journal of Public Health in Africa},
  doi = {10.4102/jphia.v17i1.1560},
  url = {https://doi.org/10.4102/jphia.v17i1.1560}
}

RIS

TY  - JOUR
TI  - Nigeria’s post-COVID-19 vaccine manufacturing ambitions: Opportunities and regional implications
AU  - Oyeronke Oyebanji
AU  - Olufunke Falade
AU  - Frederik Kristensen
AU  - David Heymann
AU  - Beate Kampmann
PY  - 2026
JO  - Journal of Public Health in Africa
DO  - 10.4102/jphia.v17i1.1560
UR  - https://doi.org/10.4102/jphia.v17i1.1560
ER  - 

APA

Oyebanji, O., Falade, O., Kristensen, F., Heymann, D., & Kampmann, B. (2026). Nigeria’s post-COVID-19 vaccine manufacturing ambitions: Opportunities and regional implications. Journal of Public Health in Africa. https://doi.org/10.4102/jphia.v17i1.1560

Source records